4//SEC Filing
OBRIEN JAMES T 4
Accession 0001088020-12-000018
CIK 0000892160other
Filed
Apr 17, 8:00 PM ET
Accepted
Apr 18, 9:47 PM ET
Size
9.1 KB
Accession
0001088020-12-000018
Insider Transaction Report
Form 4
OBRIEN JAMES T
Director
Transactions
- Tax Payment
common stock
2012-04-16$8.76/sh−4,658$40,804→ 28,042 total - Exercise/Conversion
stock option (right to buy)
2012-04-16−10,000→ 0 totalExercise: $4.08From: 2002-05-12Exp: 2012-05-12→ common stock (10,000 underlying) - Exercise/Conversion
common stock
2012-04-16$4.08/sh+10,000$40,800→ 32,700 total
Footnotes (4)
- [F1]Reflects 1-for-8 reverse stock split of common stock effective February 1, 2010.
- [F2]Shares delivered in connection with the cashless exercise of 10,000 options, previously granted pursuant to the issuer's stock option plan, at an exercise price of $4.08, as reported herein.
- [F3]The options, granted pursuant to the issuer's stock option plan, vested as to 25% on May 12, 2002, the date of the execution of the stock option agreement reflecting the grant, and vested as to an additional 25% on May 12 of 2003, 2004 and 2005.
- [F4]The options were originally granted in consideration of the reporting person's services to the issuer and without payment of cash consideration, pursuant to the issuer's stock option plan.
Documents
Issuer
DERMA SCIENCES, INC.
CIK 0000892160
Entity typeother
Related Parties
1- filerCIK 0001240136
Filing Metadata
- Form type
- 4
- Filed
- Apr 17, 8:00 PM ET
- Accepted
- Apr 18, 9:47 PM ET
- Size
- 9.1 KB